Stephanie Culler, Ph.D., is the co-founder and CEO of Persephone Biosciences Inc., a biotechnology company reimagining patient health through the development of microbiome-based medicines. Her microbiome interests span applications ranging from infant health to oncology and food as medicine. She has shared her work at TEDx San Diego, has been published in Science Magazine, and is a scientific pioneer in the field of synthetic biology. Stephanie holds a Ph.D. from the California Institute of Technology and has authored over twenty publications and patents on synthetic biology and microbial-based technologies.
